| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | XX8E5WP7FS |
| InChI Key | HVRWZFQFSQUILC-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C26H26N6O3 |
| Molecular Weight | 470.53 |
| AlogP | 4.06 |
| Hydrogen Bond Acceptor | 9.0 |
| Hydrogen Bond Donor | 1.0 |
| Number of Rotational Bond | 8.0 |
| Polar Surface Area | 102.24 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 5.0 |
| Heavy Atoms | 35.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Nerve growth factor receptor Trk-A inhibitor |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Kinase
Protein Kinase
TK protein kinase group
Tyrosine protein kinase PDGFR family
|
- | 2-2 | - | - | - | |
|
Enzyme
Kinase
Protein Kinase
TK protein kinase group
Tyrosine protein kinase Trk family
|
- | 0.1-0.1 | - | - | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Osteoarthritis | 2 | D010003 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL3673452 |
| DrugBank | DB16056 |
| FDA SRS | XX8E5WP7FS |
| Guide to Pharmacology | 10257 |
| PubChem | 118009787 |
| SureChEMBL | SCHEMBL16762937 |
| ZINC | ZINC000473215300 |